Is it mushroom poisoning or Addison's disease?February 3, 2024Reports of Amanita phalloides intoxication among dogs are relatively uncommon, but a 2022 case in California resulted in an unusual side effect.
SPONSORED CONTENTHow can you help new pet owners keep their new dogs protected?See why new dog owners and their pets can benefit from simple triple protection in one monthly chew. + See the Difference
Mushroom-poisoned dog in California develops Addison's diseaseOctober 2, 2023Sadie, a 10-year-old black Labrador retriever that had accidentally eaten death cap mushrooms, is now on lifelong treatments for Addison’s disease brought on by the poisoning.
VPN Plus+ ExclusiveA detailed look at ultrasound and vision – Part 2May 25, 2023Evaluate the cost of missing the lesion with respect to your patient, your pet owner client, your time, your team’s time, your image and report footprint, your reputation, and most of all how the cost of missing a lesion ultimately affects your art of veterinary medicine that you and your team have so painstakingly dedicated yourselves to all these years. Then look at these steps and knock off this checklist when looking at machines.
VPN Plus+ ExclusiveTaking a closer look at atypical Addison'sOctober 27, 2022The possibility of AHOC should be considered for every nonspecific GI case, particularly if the initial bloodwork is relatively unexciting or suggests a protein-losing enteropathy (low albumin and cholesterol) or GI bleeding. I screen every “chronic enteropathy” case for AHOC before pursing endoscopy or other more invasive or expensive testing.
FDA reminds vets of Zycortal Suspension amid Percorten-V shortageAugust 2, 2018Due to a shortage of Percorten-V, which is approved for use as replacement therapy for mineralocorticoid deficit in dogs with Addison's Disease, the U.S. Food and Drug Administration's Center for Veterinary Medicine is reminding veterinarians that Zycortal Suspension is an alternative treatment option that is not currently in shortage. Elanco Animal Health, manufacturer of Percorten-V (desoxycorticosterone pivalate injectable suspension), reported a manufacturing issue with the product. "Elanco is experiencing a delay in production of Percorten-V due to the inability of our contract manufacturing facility to supply product," according to the company's website. "While we work diligently to resolve this delay, there is an interruption of product supply to veterinarians. The technical challenges in the manufacturing process are being actively investigated with a focus on expediting resolution. The timeframe to resume production is dependent on the investigation conclusions and at this point is unknown. Elanco deeply regrets that this production issue is impacting the veterinarians and pets that rely on us to manage this serious disease, and is working persistently to hurry this product back to those who need it." Zycortal Suspension (desoxycorticosterone pivalate injectable suspension), also approved for use replacement therapies for mineralocorticoid …
